GeneTex Formalizes Collaboration with the Human Protein Atlas
May 5, 2026
IRVINE, Calif. - GeneTex, a multinational recombinant antibody manufacturer, is excited to announce the formalization of a collaborative relationship with the renowned Human Protein Atlas (HPA), a peerless, open-access multi-laboratory organization whose primary goal is to establish a comprehensive map of the human proteome using an integrated omics approach involving antibody-based proteomics and transcriptomics. The HPA's importance [...]
May 5, 2026
Partnership integrates RoosterBio's mesenchymal stem cell and extracellular vesicle platforms into Made Scientific's end-to-end CDMO capabilities to accelerate development and commercial-scale production of advanced therapies PRINCETON, N.J. and FREDERICK, Md. -- Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization (CDMO), and RoosterBio, Inc., a leading supplier of human mesenchymal [...]
May 4, 2026
New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical production to support the development of cell therapies for cancer, autoimmune, and other treatments WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built [...]
May 4, 2026
LOVELAND, Colo. -- Today, Hach unveils the DR4900 Spectrophotometer to meet laboratories' demand for accurate, efficient, and user-friendly water analysis. Built on Hach's legacy of trusted spectrophotometry technology since 1955, the DR4900 is a next-generation instrument engineered to empower lab professionals in municipal and industrial facilities to achieve precise results. The DR4900 maintains the trusted [...]
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences
May 4, 2026
Synthesis of structurally complex and highly-engineered protein sequences to enable acceptance of approximately 99.5% of clonal gene orders and 99.9% of all DNA products Complex synthesis capabilities to support further advancement of AI-enabled drug discovery and nucleic acid therapeutics SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, [...]
Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer
May 4, 2026
Seasoned life sciences executive brings extensive global commercial leadership to accelerate growth and expand adoption of Seer’s Proteograph® Product Suite REDWOOD CITY, Calif. -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced the appointment of Anthony Bazarko as Chief Commercial Officer. Mr. Bazarko brings more than two decades [...]
Agilent Names Michael Buckner as Chief Legal Officer
May 4, 2026
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments. [...]
May 4, 2026
La Vista, Nebraska – Streck is pleased to announce the launch of CD-Chex™ Daily, the newest addition to the CD-Chex line of flow cytometry quality controls. CD-Chex Daily is a ready-to-use, assayed quality control designed to simplify and modernize daily QC workflows for flow cytometry laboratories. CD-Chex Daily provides comprehensive coverage across 51 markers in a [...]
Distek Introduces OLERA for Reliable Dissolution Testing, Reimagined
May 1, 2026
North Brunswick, NJ – Distek, Inc., a leading manufacturer of dissolution instrumentation for 50 years, announced the release of the OLERA Dissolution Instrument Series, a new platform engineered to enhance dissolution testing through an improved user experience based on simplified operation and modern system connectivity. The OLERA Series includes three models—OLERA, OLERA Plus, and OLERA Select—designed [...]
Nanalysis Announces Board Transition and Appointment of Three New Directors
May 1, 2026
CALGARY, AB - Nanalysis Scientific Corp. (the "Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications, is pleased to announce the appointment of Jonathan Ladd, Werner Maas, and Steve Feick to its Board of Directors effective May 1, 2026. Mr. Ladd is an experienced technology [...]

